Democrats could have the upper hand going into ObamaCare negotiations this year
With a fresh check mark in the "tax reform" box, Republicans return to Capitol Hill in 2018 divided over one of the most significant legislative predicaments leading into the midterm elections: What to do with ObamaCare. Adding to troubles is the fact that the division in the GOP is countered by the unification of Democrats on the issue, giving the latter party "a strong hand to play," Politico writes.
When ObamaCare was first on the chopping block in 2017, Republicans repeatedly failed to reach a consensus on a repeal. While the individual mandate was eventually cut in the tax bill, "the reality is the GOP is so divided on ObamaCare, they don't have the votes to achieve either objective — repeal or stabilization," Politico adds. "That means former President Barack Obama's signature legislative accomplishment could keep limping along, crippled by the repeal of the individual mandate in the tax law but lifted by the surprisingly strong enrollment for the coming year."
While a Trump-approved bipartisan health-care bill is still on the table, led by Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the legislation faces longshot odds in the House. Separately, Sen. Lindsey Graham (R-S.C.) is working on reviving his own proposal to repeal ObamaCare. "I think it would be crazy if you don't" attempt a repeal again in 2018, he told Politico. "How can you repeal the individual mandate and say we're done? The thing's going to crumble. We better find a replacement that works."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Testosterone therapy in women highlights the lack of women’s health researchThe explainer There is no FDA-approved testosterone product for women
-
Magazine solutions - November 7, 2025Puzzles and Quizzes Issue - November 7, 2025
-
Magazine printables - November 7, 2025Puzzles and Quizzes Issue - November 7, 2025
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
